University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Sandy W. Wong, MD

Sandy W. Wong, MD

Assistant Clinical Professor, Division of Hematology/Oncology, UCSF

Cancer Center Program Memberships

Hematopoietic Malignancies

Education

Brown University, BA, 5/2003, Human Biology
University of Massachusetts Medical School, MD, 5/2009, Medicine
Tufts Medical Center, 6/2012, Internal Medicine Residency
Tufts Medical Center, 6/2016, Hematology/Oncology Fellowship
Tufts Medical Center, 6/2016, Amyloidosis Fellowship


Professional Experience

  • 2012-2013
    Assistant Professor, Department of Medicine, Tufts University School of Medicine, Boston, MA
  • 2016 - present
    Assistant Clinical Professor, Division of Hematology/Oncology, UCSF, San Francisco, CA

Honors & Awards

  • 2012
    Medicine Resident of the Year, Tufts Medical Center, Department of Medicine
  • 2016
    Chan Soon-Shiong Fellow, Tufts Medical Center, Division of Hematology/Oncology

Selected Publications

  1. Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, Lacy M, Lipe B, Little RF, Nikonova A, Omel J, Peswani N, Prica A, Raje N, Seth R, Vesole DH, Walker I, Whitley A, Wildes TM, Wong SW, Martin T. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline. J Clin Oncol. 2019 May 10; 37(14):1228-1263.
    View on PubMed
  2. Huang LW, Wong SW, Andreadis C, Olin RL. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma. Curr Oncol Rep. 2019 Mar 08; 21(4):35.
    View on PubMed
  3. Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C, Comenzo RL. Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth. Exp Hematol Oncol. 2018; 7:27.
    View on PubMed
  4. Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p. Clin Lymphoma Myeloma Leuk. 2018 Nov; 18(11):e493-e499.
    View on PubMed
  5. Lam C, Ferguson ID, Mariano MC, Lin YT, Murnane M, Liu H, Smith GA, Wong SW, Taunton J, Liu JO, Mitsiades CS, Hann BC, Aftab BT, Wiita AP. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica. 2018 Jul; 103(7):1218-1228.
    View on PubMed
  6. Tan M, Kalin-Hajdu E, Narayan R, Wong SW, Martin TG. Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. J Oncol Pharm Pract. 2018 Jan 01; 1078155218785967.
    View on PubMed
  7. Wong SW, Toskic D, Warner M, Varga C, Moreno-Koehler A, Fein D, Fogaren T, Lee L, Oliver CM, Guthrie SD, Comenzo RL. Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single Center. Clin Lymphoma Myeloma Leuk. 2017 11; 17(11):759-766.
    View on PubMed
  8. Wong SW, Larivee D, Warner M, Sprague KA, Fogaren T, Comenzo RL. Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy. Bone Marrow Transplant. 2017 06; 52(6):936-937.
    View on PubMed
  9. Sandy W. Wong, Melissa Warner, Alejandro Moreno-Koehler, Athena Kritharis, Michael E. Coyle, Deborah Black, Valerie Relias, Terry Fogaren, Nancy Cody Lyons, Francois Toka, Denise Larivee, Andrew M. Evens, Grace Kao, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo. Toxicities, response and survival: Autologous stem cell transplantation for multiple myeloma over 25 years at a single center. Cancer Treatment and Research Communications. 2017; 11:1-5.
    View on PubMed
  10. Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. siRNA targeting the ? light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases. Gene Ther. 2016 10; 23(10):727-733.
    View on PubMed
  11. Weiss BM, Wong SW, Comenzo RL. Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis. Blood. 2016 05 12; 127(19):2275-80.
    View on PubMed
  12. Wong SW, Comenzo RL. CD38 Monoclonal Antibody Therapies for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):635-45.
    View on PubMed
  13. Yuan Z, Liu X, Wong S, Machan JT, Chung MA. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. J Surg Res. 2009 Nov; 157(1):e39-46.
    View on PubMed
  14. Yuan Z, Wong S, Borrelli A, Chung MA. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun. 2007 Oct 26; 362(3):740-6.
    View on PubMed
  15. Shaw MH, Boyartchuk V, Wong S, Karaghiosoff M, Ragimbeau J, Pellegrini S, Muller M, Dietrich WF, Yap GS. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11594-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI